Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113048
Status:
TERMINATED
Last Update Posted:
2014-02-05
First Post:
2005-06-03
Brief Title:
Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies
Sponsor:
Organization:
Sanofi